News
The DLB crew breaks down Alex Ovechkin's legacy after breaking the NHL's all-time goals record, questioning how much the legend has left in the tank at 39 years old.
A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...
Learn more about whether Dolby Laboratories, Inc. or Procore Technologies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
People with Parkinson’s are up to six times more likely to develop dementia. This is called Parkinson’s disease dementia.
1dOpinion
Zacks Investment Research on MSN3 Audio Video Stocks to Consider From a Flourishing IndustryThe Zacks Audio Video Production industry participants are concentrating on the premium segment of the branded products ...
Sonos (SONO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
The ClearBridge Growth Strategy underperformed its Russell Midcap Growth Index benchmark in the first quarter. Read more here.
Nitrated α-synuclein is upregulated in the CSF of patients with Parkinson’s Disease (PD), Lewy body dementia (DLB), multiple system atrophy (MSA), and other synucleinopathies.
MINOT,N.D.–The DLB-LC Lakers softball team put on a show at home, as they took down the New Town Eagles 22-0. ...
Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the ...
A new study by the University of Turku and Turku University Hospital, Finland, found that a significant proportion of Parkinson's disease diagnoses are later corrected.
A study found that a significant proportion of Parkinson's disease diagnoses are later corrected. Up to one in six diagnoses changed after ten years of follow-up, and the majority of new diagnoses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results